Blog

Today QCMD: runs 100+ molecular EQA schemes for infectious diseases receives 15,000+ participant registrations annually serves laboratories in 120+ countries collaborates with a broad international network of highly engaged experts from clinical

During the 2022-2023 mpox outbreak, QCMD develops and launches an international EQA scheme at short notice, in collaboration with the Bundeswehr Institute of Microbiology in Munich. The scheme helps laboratories worldwide validate

Together with partners from the RECOVER project and collaborating networks (PREPARE, COMBACTE LAB-Net and EVD-LabNet), QCMD quickly provides laboratories worldwide with one of the earliest available molecular EQA schemes, helping verify assay

As molecular diagnostics evolve from single-target PCR to multiplex syndromic testing, sequencing and genomics, QCMD broadens its EQA portfolio accordingly. New scheme areas include: Respiratory and STI panels (for diverse microbiology targets)

Participant registrations exceed 10,000 for the first time, across 96 countries.

QCMD distributes an outbreak-related EQA to help laboratories in Latin America, the Caribbean and other affected countries worldwide. Its swift introduction is made possible by collaboration with the Paul Ehrlich Institute. This

A new version of ITEMS (QCMD’s online EQA management system) is launched. It supports the entire EQA lifecycle and introduces many new features, including a participant management dashboard, reusable workflows and a

By 2009, MALDI-TOF has been widely introduced into routine clinical laboratories as a reliable method for identifying bacteria and fungi. Its ease of use and cost-effectiveness lead to the integration of MALDI-TOF

QCMD is first accredited to ISO/IEC 17043 by UKAS, strengthening its role as an internationally recognised provider of molecular proficiency testing. Until then, QCMD’s quality management system is certified to ISO 9001,

QCMD evolves from a European initiative into a global EQA organisation, extending coverage to more pathogens, targets and applications (e.g., detection, quantification, genotyping, sequence analysis). Two important developments for emerging pathogens are